Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.
The adoption of digital health may not be about the speed, nor the idea itself, but rather how well the idea is tailored to suit the unique and complex world of healthcare.
Viruses are the ultimate freeloaders. The best among them — influenza, smallpox and SARS-CoV-2 — spread easily among human hosts while delivering high mortality...